Innovative Ovulation Tracker: From Concept to FDA-Approval in Nine Months

Molecular biologist Amy Beckley named GenXYZ 2018 for MFB Fertility

AMY BECKLEY, 37

OWNER, MFB FERTILITY, BOULDER

Molecular biologist Beckley’s own battle with infertility underlies her passion to help other women and inspired her crowdfunding campaign to create and market a new ovulation tracking device. After raising $40,000, Beckley went from concept to FDA-registered product in just nine months.

She also has launched a nonprofit arm of her company to donate a portion of the profits to educate women about fertility, help them conceive and provide resources for pregnant women.

Categories: GenXYZ